| Name | Title | Contact Details |
|---|
Chem Rx Corporation, formerly Paramount Acquisition Corp., provides institutional pharmacy services to skilled nursing facilities, assisted living facilities, residential living facilities, addiction treatment centers and other long-term healthcare
B&D Consulting is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Los Angeles Biomedical Research Institute is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Los Angeles Biomedical Research Institute is based in Torrance, CA. You can find more information on Los Angeles Biomedical Research Institute at www.labiomed.org
"Gentiva Health Services (NASDAQ: GTIV), formerly based in Melville, Long Island, New York and now in Atlanta, Georgia, is the largest provider of home health care, hospice and related services in the United States. Gentiva is a Fortune 1000 company with $1.7 billion in annual revenue. Gentiva is also a member of the S&P 600 index, developed by Standard and Poor's, featuring small capitalization U.S.-based stocks. The company offers a range of services, including nursing, physical, occupational, and speech-language therapy, cardiac and pulmonary care, disease and pain management, and other health and medical services. Gentiva provides health services to over half a million patients annuallythrough over 380 U.S. locations in 39 states. According to Morningstar, "Gentiva is a gentle giant...the nation's largest home health care services firm." Gentiva companies include Donelson, Emerald Coast, Gilbert's, Healthfield Group, Heritage, Horizon, Hospice of Charleston, Lazarus House, Tar Heel, Total Care and Wiregrass."
Xtant Medical (NYSE MKT: XTNT) develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. Xtant products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, and foot and ankle surgeries. With core competencies in both biologic and non-biologic surgical technologies, Xtant can leverage its resources to successfully compete in global neurological and orthopedic surgery markets.